Beeline Medicines

About Beeline Medicines

Beeline Medicines is a clinical-stage biotechnology company focused on developing precision therapies that directly address immune dysfunction in autoimmune and inflammatory diseases. Led by a portfolio including afimetoran, a TLR7/8 inhibitor for lupus, the company aims to advance best-in-class therapies with rapid, meaningful impact on patients’ lives. Its pipeline also features IL-10 and TYK2-targeted programs, with a foundation in validated biology and differentiated molecular properties. Headquartered in the United States, Beeline Medicines is advancing treatments intended to restore immune balance across systemic and organ-specific manifestations of autoimmune conditions.